Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

The intricate landscape of medical research continues to unveil groundbreaking approaches to managing chronic joint health ...

A total of nearly 137 million adults, representing more than half of all U.S. adults, are eligible for semaglutide therapy. This ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss and blood sugar management. But did ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...